Skip to content
Medical Health Aged Care

Hospital pressure shows it’s not too late for flu shot: RACGP

Royal Australian College of GPs 3 mins read
 

The Royal Australian College of GPs (RACGP) is urging Australians who have not received this year’s influenza vaccine to book an appointment with their GP, warning that a rapid rise in winter illness can tip already stretched hospitals over the edge. 

The call follows a record winter day for Sydney’s emergency departments, with almost 10,000 presentations and 4,100 ambulance callouts.  

RACGP President Dr Michael Wright said Sydney’s experience should serve as a warning for the rest of the country. 

“Flu is not the only reason hospitals are under pressure, but when they are already operating at or near capacity, a sudden rise in preventable winter illness can tip them over the edge,” he said. 

“Sydney has shown how quickly the pressure can build. Flu seasons are unpredictable, and we should not assume this year’s lower numbers mean we are in the clear. 

“Vaccination is one of the simplest steps you can take to protect yourself, your family and the people around you. If you haven’t received your flu vaccine yet, book with your GP.” 

Last year showed that influenza does not always follow the usual winter timetable, with cases rising in late October and remaining unusually high into December. Since the start of the year, Australia has recorded 65,837 laboratory-confirmed influenza notifications, with July's reported flu cases (20,607) the highest so far in 2026 – nearly double June (10,709), and five times the number reported in May.  

The figures show the significant impact influenza can have on children. More than 17,600 notifications have been recorded among children under 10 – more than one in four of all recorded cases this year.  

Dr Wright said families should not underestimate how seriously influenza can affect children. 

“For parents, this is not just about avoiding a few days away from school or childcare. Flu can make children extremely unwell,” he said. 

“No parent wants to see their child struggling with a high fever, unable to eat or drink, or becoming sick enough to need hospital care. 

“Vaccinating now could prevent a frightening illness for your child and help stop flu spreading through your family.” 

Needle-free vaccines are available at no cost for children aged 2–4 in New South Wales, Queensland, Western Australia and South Australia, with some states extending access to older children. 

Families in Victoria, Tasmania, the ACT and the Northern Territory must currently pay privately for a needle-free vaccine. The RACGP continues to call on these governments to provide free access. 

Dr Wright said vaccination must form part of a broader commitment to prevention and primary care. 

“Australians can help protect themselves through vaccination, but governments must also do their part,” he said. 

“We cannot keep relying on emergency departments as the first and last line of defence. Long-term underinvestment in prevention and general practice has resulted in people missing out on care until they become seriously unwell. 

“Investing in general practice helps people stay healthy, receive care earlier and avoid hospital. That is better for patients, better for families and better for the entire health system.” 

Annual influenza vaccination is recommended for everyone aged six months and older. Free vaccines are available under the National Immunisation Program for eligible groups, including young children, pregnant people, Aboriginal and Torres Strait Islander people, people aged 65 and older, and people with certain medical conditions. 

Anyone experiencing flu symptoms should stay home where possible, avoid contact with people at higher risk of serious illness, and speak to their GP early if they are concerned or at increased risk of complications.

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the voice of general practitioners (GPs) in our growing cities and throughout rural and remote Australia. For more than 60 years, we’ve supported the backbone of Australia’s health system by setting the standards for education and practice and advocating for better health and wellbeing for all Australians.

View more RACGP media releases on our website. To unsubscribe from RACGP media releases, contact Medianet or update your preferences.


Contact details:

Stuart Winthrope
Media Advisor

Dominique Yohanes
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

More from this category

  • Medical Health Aged Care
  • 16/09/2026
  • 15:09
Galderma

Galderma’s Restylane® Volyme(TM) Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing,…

  • Contains:
  • Medical Health Aged Care
  • 16/09/2026
  • 15:00
Royal Australian College of GPs

RACGP welcomes investment in GP services for Nhulunbuy

The Royal Australian College of GPs (RACGP) has welcomed the announcement that Top End Medical Centre will establish an ongoing general practice service in Nhulunbuy, helping improve access to essential healthcare for communities across the East Arnhem region. The new service, supported by Australian Government funding and coordinated through the Northern Territory Primary Health Network (NT PHN), will commence from 12 October and deliver comprehensive GP care in Nhulunbuy. Services are expected to include preventive healthcare, chronic disease management, mental health care, women's, men's and children's health services, immunisations and telehealth. RACGP President Dr Michael Wright said improving access to…

  • Contains:
  • Medical Health Aged Care
  • 16/09/2026
  • 14:37
Cambium Bio Limited

Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease

Strategic shareholders commit A$7.1 million at a premium to market, the Company’s fourth consecutive equity raise priced at a premium, alongside A$3.75 million of non-dilutive R&D Tax Incentive pre-financingSYDNEY, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Cambium Bio Limited (ASX: CMB) (“Cambium Bio” or the “Company”), a clinical-stage regenerative medicine company developing biologic therapies for ophthalmology, today announced that it has secured an A$10.85 million funding package to initiate its pivotal Phase 3 trial of Elate Ocular® in moderate to severe dry eye disease (“DED”). The package comprises A$7.1 million (US$5.0 million) in firm commitments from strategic shareholders through a placement…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.